Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Emerson enters the fiscal-year close with strong demand and execution: third-quarter underlying orders rose 7%, underlying sales rose 6%, adjusted segment EBITA margin reached 28.5%, and adjusted EPS increased 13%. The portfolio offers attractive exposure to power, LNG, life sciences, semiconductors, aerospace and defense, while the $9.6 billion backlog provides near-term visibility. However, the August 28 closing price of $155.18 already discounts substantial progress toward management's FY2028 targets. The resulting base-case price appreciation is modest, while acquisition integration, elevated leverage, regional weakness and geopolitical disruption remain material counterweights.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets27 analysts · as of 18 Aug 2026
Low · most bearish analyst$104.00
Mean target$171.07
High · most bullish analyst$205.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 2 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$104.0020%

Twelve-month bear case: industrial demand weakens, backlog declines below $9 billion, underlying orders turn non-positive, and adjusted segment EBITA margin falls below 27%. Higher interest expense, integration complexity, restructuring and weakness in Europe or China reduce confidence in the FY2028 framework and compress the valuation.

Base CaseCentral scenario
$171.0755%
Matches the consensus mean

Twelve-month base case: Emerson delivers approximately $6.55 of FY2026 adjusted EPS, maintains positive underlying orders, and advances toward the FY2028 targets of $21 billion in sales, 30% adjusted segment EBITA margin and $8.00 adjusted EPS.

Bull CaseUpside scenario
$205.0025%

Twelve-month bull case: orders remain at high-single-digit growth, Test & Measurement and industrial software sustain above-company growth, backlog converts on schedule, and margin expansion makes the FY2028 targets appear conservative. Successful AspenTech and NI integration, AI-enabled product adoption and continued repurchases support a higher quality-growth valuation.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Third-quarter execution was strong across demand, sales, profitability and cash generation: underlying orders increased 7%, net sales increased 7%, adjusted segment EBITA margin expanded to 28.5%, adjusted EPS increased 13%, and free cash flow increased 36%.
  • Software & Systems grew 11% in the third quarter, including 23% growth in Test & Measurement, while the $9.6 billion contract backlog provides revenue visibility and approximately 75% is expected to convert within twelve months.
  • Management's FY2028 framework targets $21 billion of sales, 30% adjusted segment EBITA margin, $8.00 adjusted EPS, $12 billion of cumulative free cash flow and $10 billion of shareholder returns.
Sign in / Sign up to read more
Key Investment Risks
  • Leverage remains elevated following the AspenTech transaction: net debt to net capital was 34.9% and twelve-month interest coverage was 8.2 times at June 30, 2026, versus 9.6 times one year earlier.
  • At June 30, 2026, Emerson carried $18.1 billion of goodwill and $8.7 billion of other intangible assets, increasing exposure to integration underperformance, amortization and potential impairment if acquired businesses miss expectations.
  • Demand is geographically uneven and exposed to geopolitical disruption: third-quarter Europe sales declined 1%, China declined 3%, and management identified the Middle East conflict as an ongoing uncertainty.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.